ARTL ▼ -2.1% - Artelo Biosciences, Inc.
$ARTL - Artelo Biosciences Selected for its First-Ever Company Presentation at BIO-Europe 2026 to Showcase Clinical Progress and Expanding Potential of its Novel FABP5 Inhibitor Platform
07-OCT-2026 08:48 AM ET
Share this post
More filings for $ARTL
ARTL ▲ +66.5% - Artelo Biosciences, Inc.Sep 23, 2026ARTL ▼ -7.4% - Artelo Biosciences, Inc.Sep 23, 2026ARTL ▼ -9.8% - Artelo Biosciences, Inc.Sep 16, 2026ARTL ▲ +1.0% - Artelo Biosciences, Inc.Sep 8, 2026ARTL ▼ -29.6% - Artelo Biosciences, Inc.Aug 27, 2026ARTL - Artelo Biosciences, Inc. - SEC Filing Update (14-AUG-2026) | ThinkSabio - Stocks SimplifiedAug 14, 2026
View full $ARTL filing history →💬 Comments
Loading comments…
Leave a comment